The researchers found no difference between subcutaneous and oral semaglutide for constipation
However, age, gender, BMI, but also diet- and physical activity dependent differences in FA and lipid composition are well documented findings 77,78 , which should be taken into consideration for the generalizability of the results
But unless theyre as bad at math as he is, theyll realize that this is a huge benefit with little cost in the longer run
So, is this a perfect tsunami of those two coming together, and these two things of IRA uncertainty, uncertainty with regards to the regulatory issues, with regards to approval process at the FDA, and creating a very huge barrier for not only new drugs coming out, but these labeling extensions that Peter talked about, which is, are we going invest more money to research an existing drug in the market, or were just going to pull back everything